Mokrowiecka A, Kopczynska M, Borkowska A, Malecka-Wojciesko E
J Clin Med. 2025; 14(3).
PMID: 39941688
PMC: 11818520.
DOI: 10.3390/jcm14031018.
Mokros L, Domzal-Magrowska D, Pietras T, Sipowicz K, Talar-Wojnarowska R
Life (Basel). 2021; 11(12).
PMID: 34947878
PMC: 8706576.
DOI: 10.3390/life11121347.
Graff L, Fowler S, Jones J, Benchimol E, Bitton A, Huang J
J Can Assoc Gastroenterol. 2021; 4(Suppl 2):S46-S53.
PMID: 34755039
PMC: 8570421.
DOI: 10.1093/jcag/gwab031.
Uwagbale E, Adeniran O, Adeniran O, Onukogu I, Agbroko S, Sonpal N
Cureus. 2021; 13(7):e16566.
PMID: 34430168
PMC: 8380051.
DOI: 10.7759/cureus.16566.
Barello S, Guida E, Leone S, Previtali E, Graffigna G
Health Qual Life Outcomes. 2021; 19(1):77.
PMID: 33678181
PMC: 7938585.
DOI: 10.1186/s12955-021-01724-w.
Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians.
Sinagra E, Utzeri E, Morreale G, Fabbri C, Pace F, Anderloni A
World J Clin Cases. 2020; 8(6):1013-1025.
PMID: 32258072
PMC: 7103973.
DOI: 10.12998/wjcc.v8.i6.1013.
Gastrointestinal Symptoms of and Psychosocial Changes in Inflammatory Bowel Disease: A Nursing-Led Cross-Sectional Study of Patients in Clinical Remission.
Mancina R, Pagnotta R, Pagliuso C, Albi V, Bruno D, Garieri P
Medicina (Kaunas). 2020; 56(1).
PMID: 31968710
PMC: 7022245.
DOI: 10.3390/medicina56010045.
Associations between disease activity, social support and health-related quality of life in patients with inflammatory bowel diseases: the mediating role of psychological symptoms.
Fu H, Kaminga A, Peng Y, Feng T, Wang T, Wu X
BMC Gastroenterol. 2020; 20(1):11.
PMID: 31937264
PMC: 6961247.
DOI: 10.1186/s12876-020-1166-y.
Incidence and temporal trends of co-occurring personality disorder diagnoses in immune-mediated inflammatory diseases.
Blaney C, Sommer J, El-Gabalawy R, Bernstein C, Walld R, Hitchon C
Epidemiol Psychiatr Sci. 2020; 29:e84.
PMID: 31915099
PMC: 7214704.
DOI: 10.1017/S2045796019000854.
The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.
Jones J, Nguyen G, Benchimol E, Bernstein C, Bitton A, Kaplan G
J Can Assoc Gastroenterol. 2019; 2(Suppl 1):S42-S48.
PMID: 31294384
PMC: 6512247.
DOI: 10.1093/jcag/gwy048.
Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome.
Guadagnoli L, Mutlu E, Doerfler B, Ibrahim A, Brenner D, Taft T
Qual Life Res. 2019; 28(8):2195-2205.
PMID: 30900206
PMC: 6625837.
DOI: 10.1007/s11136-019-02170-4.
Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United States.
Xu F, Liu Y, Wheaton A, Rabarison K, Croft J
Appl Health Econ Health Policy. 2018; 17(1):77-91.
PMID: 30259396
PMC: 10498392.
DOI: 10.1007/s40258-018-0432-4.
Advanced Age Does Not Negatively Impact Health-Related Quality of Life in Inflammatory Bowel Disease.
Perera L, Bhandari S, Liu R, Guilday C, Zadvornova Y, Saeian K
Dig Dis Sci. 2018; 63(7):1787-1793.
PMID: 29713985
DOI: 10.1007/s10620-018-5076-6.
Altered Brain Excitability and Increased Anxiety in Mice With Experimental Colitis: Consideration of Hyperalgesia and Sex Differences.
Nyuyki K, Cluny N, Swain M, Sharkey K, Pittman Q
Front Behav Neurosci. 2018; 12:58.
PMID: 29670513
PMC: 5893896.
DOI: 10.3389/fnbeh.2018.00058.
Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment.
Bedell A, Taft T, Craven M, Guadagnoli L, Hirano I, Gonsalves N
Dig Dis Sci. 2018; 63(5):1148-1157.
PMID: 29476289
PMC: 6701628.
DOI: 10.1007/s10620-018-4978-7.
Market share and costs of biologic therapies for inflammatory bowel disease in the USA.
Yu H, MacIsaac D, Wong J, Sellers Z, Wren A, Bensen R
Aliment Pharmacol Ther. 2017; 47(3):364-370.
PMID: 29164650
PMC: 5760274.
DOI: 10.1111/apt.14430.
Symptom clusters in adults with inflammatory bowel disease.
Conley S, Proctor D, Jeon S, Sandler R, Redeker N
Res Nurs Health. 2017; 40(5):424-434.
PMID: 28833284
PMC: 5597486.
DOI: 10.1002/nur.21813.
Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease.
Luo X, Mao R, Chen B, Qiu Y, Zhang S, He Y
Patient Prefer Adherence. 2017; 11:23-31.
PMID: 28053510
PMC: 5189695.
DOI: 10.2147/PPA.S118589.
Participants' perspectives on mindfulness-based cognitive therapy for inflammatory bowel disease: a qualitative study nested within a pilot randomised controlled trial.
Schoultz M, Macaden L, Hubbard G
Pilot Feasibility Stud. 2016; 2:3.
PMID: 27965824
PMC: 5153874.
DOI: 10.1186/s40814-015-0041-z.
Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease.
Freitas T, Andreoulakis E, Alves G, Miranda H, Braga L, Hyphantis T
World J Gastroenterol. 2015; 21(21):6713-27.
PMID: 26074710
PMC: 4458782.
DOI: 10.3748/wjg.v21.i21.6713.